-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
Q1 2026 was a double beat for CLS, and we maintain our Buy rating. More impressive than the beats was that guidance for 2026 was significantly increased from just a quarter ago. The 2026 revenue guidance was raised to $19.0B (from $17.0B) and adjusted EPS was increased to $10.15 (from $8.75), representing over $6.5B in revenue growth for the year. Additionally, its first CPO program was won with a hyperscaler, indicating the importance of CLS proprietary tech and cutting edge solutions (1.6T, optics). We increased our target price to CAD565 from CAD504. This is derived from our unchanged earnings multiple of 30x and unchanged EBITDA multiple of 24x our 2027 projections. We now expect revenue growth of +50% in 2026 and ~35% in 2027, with incremental operating leverage. We increase our 2026 EPS to $10.20 (from $9.18) and 2027's to $13.92 (from $11.98).